0

Journal Articles

in Drug Therapy
 121-140 of 342 Articles
Medical News and Perspectives |  September 21, 2011
New Physician Education Initiatives Seek to Remove the Devil From the Detailing
Mike Mitka
JAMA. 2011;306(11):1187-1188. doi:10.1001/jama.2011.1256.
Editorial |  August 24, 2011
Going Home on the Right Medications:  Prescription Errors and Transitions of Care
Jeremy M. Kahn, MD, MS; Derek C. Angus, MD, MPH
JAMA. 2011;306(8):878-879. doi:10.1001/jama.2011.1209.
Medical News and Perspectives |  August 10, 2011
European Drug Agency Under Fire
Tracy Hampton, PhD
JAMA. 2011;306(6):593-595. doi:10.1001/jama.2011.1102.
Health Agencies Update |  July 27, 2011
Drug Name Confusion
Tracy Hampton, PhD
JAMA. 2011;306(4):366. doi:10.1001/jama.2011.1012.
Commentary |  July 20, 2011
Facilitating Clinical Implementation of Pharmacogenomics
David A. Mrazek, MD, FRCPsych; Caryn Lerman, PhD
JAMA. 2011;306(3):304-305. doi:10.1001/jama.2011.1010.
Editorial |  July 20, 2011
Reducing the Long-term Effects of Chemotherapy in Young Women With Early-Stage Breast Cancer
Hope S. Rugo, MD; Mitchell P. Rosen, MD
JAMA. 2011;306(3):312-314. doi:10.1001/jama.2011.1019.
Capitol Health Call |  July 13, 2011
Price Gouging?
Mike Mitka
JAMA. 2011;306(2):145. doi:10.1001/jama.2011.925.
Lab, Field, and Clinic |  July 13, 2011
Data Mining Approach Shows Promise in Detecting Unexpected Drug Interactions
Tracy Hampton, PhD
JAMA. 2011;306(2):144. doi:10.1001/jama.2011.918.
Medical News & Perspectives |  June 15, 2011
Medical Students’ Paradox: Drug Company Materials Biased Yet Helpful, They Say
Rebecca Voelker
JAMA. 2011;305(23):2401. doi:10.1001/jama.2011.829.
Medical News & Perspectives |  May 11, 2011
Proposals Seek to Reduce Resistance, Boost Development of New Antibiotics
Bridget M. Kuehn
JAMA. 2011;305(18):1845-1846. doi:10.1001/jama.2011.598.
Brief Report |  May 04, 2011 FREE
Availability of Comparative Efficacy Data at the Time of Drug Approval in the United States
Nikolas H. Goldberg; Sebastian Schneeweiss, MD, ScD; Mary K. Kowal, BA; et al.
JAMA. 2011;305(17):1786-1789. doi:10.1001/jama.2011.539.
Research Letters |  April 06, 2011 FREE
Characteristics of Opioid Prescriptions in 2009
Nora D. Volkow, MD; Thomas A. McLellan, PhD; Jessica H. Cotto, MPH; et al.
JAMA. 2011;305(13):1299-1301. doi:10.1001/jama.2011.401.
Commentary |  March 23, 2011
A National Registry for Healthy Volunteers in Phase 1 Clinical Trials
David B. Resnik, JD, PhD; Greg Koski, MD, PhD
JAMA. 2011;305(12):1236-1237. doi:10.1001/jama.2011.354.
Commentary |  March 16, 2011
Statistical Association and Causation:  Contributions of Different Types of Evidence
Charles H. Hennekens, MD, DrPH; David DeMets, PhD
JAMA. 2011;305(11):1134-1135. doi:10.1001/jama.2011.322.
Medical News & Perspectives |  March 16, 2011
New “Law” Attempts to Explain Strategies Drug Marketers Use to Sway Prescribing
Mike Mitka
JAMA. 2011;305(11):1083-1084. doi:10.1001/jama.2011.285.
Capitol Health Call |  March 09, 2011
Delay for Generics
Mike Mitka
JAMA. 2011;305(10):987. doi:10.1001/jama.2011.263.
Commentary |  March 09, 2011
Preserving the Lifesaving Power of Antimicrobial Agents
James M. Hughes, MD
JAMA. 2011;305(10):1027-1028. doi:10.1001/jama.2011.279.
Medical News & Perspectives |  March 09, 2011
FDA Takes Slow Road Toward Withdrawal of Drug Approved With Fast-Track Process
Mike Mitka
JAMA. 2011;305(10):982-984. doi:10.1001/jama.2011.269.
Medical News & Perspectives |  February 16, 2011
Study: Few Advocacy Groups Disclose Grants From Drug Companies
Rebecca Voelker
JAMA. 2011;305(7):662. doi:10.1001/jama.2011.119.
Capitol Health Call |  February 09, 2011
Outsourcing Questioned
Mike Mitka
JAMA. 2011;305(6):553. doi:10.1001/jama.2011.97.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  |  May 13, 2013
Adulterated Sexual Enhancement Supplements:  More Than Mojo
Pieter A. Cohen, MD; Bastiaan J. Venhuis, PhD
JAMA Internal Medicine
Research Letters  |  April 22, 2013
Developing a Model for Attending Physician Workload and Outcomes
Henry J. Michtalik, MD, MPH, MHS; Peter J. Pronovost, MD, PhD; Jill A. Marsteller, PhD, MPP; et al.
JAMA Internal Medicine
Viewpoint  |  March 25, 2013
Surrogate Outcomes in Clinical Trials:  A Cautionary Tale
Staffan Svensson, MD, PhD; David B. Menkes, MD, PhD; Joel Lexchin, MSc, MD
JAMA Internal Medicine
Invited Commentary  |  February 4, 2013
Are Calcium Supplements Harmful to Cardiovascular Disease?:  Comment on “ Dietary and Supplemental Calcium Intake and Cardiovascular Diseases Mortality: The National Institutes of Health–AARP Diet and Health Study”
Susanna C. Larsson, PhD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems